Year | Volume (Price x Shares) | Change |
---|---|---|
2023 | $29.35 M | -81.12% |
2022 | $0.15 B | 200.46% |
2021 | $51.74 M | -9.83% |
2020 | $57.38 M | 52.34% |
2019 | $37.66 M | 46.52% |
2018 | $25.7 M | -70.97% |
2017 | $88.54 M | 191.96% |
2016 | $30.32 M | -14.94% |
2015 | $35.65 M | 68.07% |
2014 | $21.21 M | 152.1% |
2013 | $8.41 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
![]() Novartis NVS | $29.28 M | $71.27 M | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | $7.71 M | $0.11 B | ๐ซ๐ท France |
![]() Regeneron Pharmaceuticals REGN | $14.42 M | $79.47 M | ๐บ๐ธ USA |
![]() Sarepta Therapeutics
SRPT | $5.5 M | $20.45 M | ๐บ๐ธ USA |
![]() Regulus Therapeutics RGLS | N/A | $0.29 M | ๐บ๐ธ USA |
![]() OPKO Health
OPK | $1.39 M | $13 M | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $19.7 M | $51.29 M | ๐ฎ๐ฑ Israel |
![]() Arrowhead Pharmaceuticals
ARWR | $1.55 M | $4.89 M | ๐บ๐ธ USA |